Concepedia

Angelica Messana

AM

Statistics

Publications

7

Citations

259

H-Index

7

Active since

2017

Affiliations

Broad Institute(Current)

Harvard University

Harvard Stem Cell Institute

Beam Therapeutics (United States)

Angelica Messana is an author at Broad Institute specializing in life sciences, genetics, and crispr-cas9 genome editing.

ORCID

Publications per year

2017–2024

7

Publications

7

Cytosine base editing enables quadruple-edited allogeneic CART cells for T-ALL

Caroline Diorio, Ryan Murray, Mark Naniong et al. · Blood · 2022 · 131 citations · Full text

, , +17

A multiplexed gRNA piggyBac transposon system facilitates efficient induction of CRISPRi and CRISPRa in human pluripotent stem cells

Dane Z. Hazelbaker, Amanda Beccard, Gabriella Angelini et al. · Scientific Reports · 2020 · 41 citations · Full text

, , +17

De novo DNA methyltransferases DNMT3A and DNMT3B are essential for XIST silencing for erosion of dosage compensation in pluripotent stem cells

Atsushi Fukuda, Dane Z. Hazelbaker, Nami Motosugi et al. · Stem Cell Reports · 2021 · 29 citations · Full text

, , +16

A Scaled Framework for CRISPR Editing of Human Pluripotent Stem Cells to Study Psychiatric Disease

Dane Z. Hazelbaker, Amanda Beccard, Anne M. Bara et al. · Stem Cell Reports · 2017 · 22 citations · Full text

, , +14

Immunosuppressant therapy averts rejection of allogeneic FKBP1A-disrupted CAR-T cells

Colby R. Maldini, Angelica Messana, Paula B. Bendet et al. · Molecular Therapy · 2024 · 13 citations · Full text

, , +7

1–5 of 7